Business Insider

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA ...
FierceBiotech

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Route

First Presentation of Full Data Set from the TRIUMPH-1 Trial of Inhaled Treprostinil SILVER SPRING, Md., May 21, 2008 -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary ...
Monthly Prescribing Reference

Implantable System for Remodulin Approved for Patients With PAH

Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension. The New Drug Application (NDA) for the use of Remodulin (treprostinil; United Therapeutics) ...
FierceBiotech

Medtronic, United receive approval for fully implantable PAH infusion pump

Medtronic and United Therapeutics received premarket approval from the FDA for a fully implantable drug delivery system that continuously administers Remodulin (treprostinil) through a cardiac ...